Difference between revisions of "BioCommercialization.com"
(→Description) |
(migration import) |
||
Line 1: | Line 1: | ||
+ | {{DISPLAYTITLE:BioCommercialization.com is a resource for commercialization of life sciences technology}} | ||
{{ Domain_Page | | {{ Domain_Page | | ||
reviews = <reviews></reviews> | | reviews = <reviews></reviews> | | ||
Line 34: | Line 35: | ||
* [http://whois.domaintools.com/biocommercialization.com WHOIS for BioCommercialization.com] | * [http://whois.domaintools.com/biocommercialization.com WHOIS for BioCommercialization.com] | ||
+ | |||
+ | __NOTOC__ | ||
+ | [[Category:Biocommercialization]] | ||
+ | [[Category:Biologics]] | ||
+ | [[Category:Biopharmaceutical]] | ||
[[Category:Biotechnology]] | [[Category:Biotechnology]] | ||
[[Category:Commercialization]] | [[Category:Commercialization]] | ||
+ | [[Category:Funding]] | ||
+ | [[Category:Intellectual Property]] | ||
+ | [[Category:Licensing]] | ||
[[Category:Life Sciences]] | [[Category:Life Sciences]] | ||
+ | [[Category:Marketing]] | ||
+ | [[Category:Missouri]] | ||
+ | [[Category:Patent]] | ||
+ | [[Category:Pharmaceutical Commercialization]] | ||
[[Category:Pharmaceuticals]] | [[Category:Pharmaceuticals]] | ||
− | |||
− | |||
− | |||
[[Category:Regulatory]] | [[Category:Regulatory]] | ||
− | |||
− | |||
[[Category:Investing]] | [[Category:Investing]] | ||
− | [[Category: | + | [[Category:Intellectual_Property]] |
− | + | [[Category:Life_Sciences]] | |
− | + | [[Category:Medical_Device]] |
Revision as of 19:39, 12 November 2013
Title
BioCommercialization || Pharmaceutical, Medical Device and Biotechnology Commercialization Resources
Description
BioCommercialization is a resource for professionals who translate biomedical research innovations into developed products - pharmaceutical, medical device and biotechnology commercialization. Philadelphia patent attorney Kevin Buckley created this forum to address what he is deeply committed to in his business life - speeding technology innovations to market while enhancing the potential for increased licensing and royalty revenue, investor funding, regulatory approval, sales revenue and reaching the market more efficiently.
Languages
English